Historical record - last NADAC publication: 6/22/2016
Product Information
MORPHINE SULFATE ER 60 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $8.9771 per EA under NDC 00228309111. Its NADAC has been published 165 times since May 21, 2014.
The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228309111
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/22/2016
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA079040On Market Since
2/4/2014
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 60 MG CAP has been published 165 times since May 21, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9771 per EA |
|---|---|
| All-time high | $9.8664 (Oct 15, 2014) |
| All-time low | $8.9499 (Jun 18, 2014) |
| Median price | $9.3109 |
| Average price | $9.2730 |
| Largest weekly change | -7.1% (Jun 22, 2016) |
| Weeks tracked | 165 |
| Tracking since | May 21, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 60 MG CAP, manufactured by Actavis Pharma, Inc., is $8.9771 per EA (NDC 00228309111), effective Jul 12, 2017.
How has the price of MORPHINE SULFATE ER 60 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 60 MG CAP has held within roughly two percent of its current level. It has been tracked across 165 weekly CMS publications since May 21, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 60 MG CAP?
Since May 21, 2014, the NADAC for MORPHINE SULFATE ER 60 MG CAP has ranged from a low of $8.9499 (Jun 18, 2014) to a high of $9.8664 (Oct 15, 2014), with a median of $9.3109 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 60 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 60 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 60 MG CAP?
MORPHINE SULFATE ER 60 MG CAP (NDC 00228309111) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification